Exit events / 931
#931
| id | 931 |
|---|---|
| company_id | 13499 |
| event_type | acquisition |
| event_date | — |
| counterparty_company_id | 17193 |
| successor_company_id | — |
| deal_value_usd | 4100000000.0 |
| deal_value_basis | reported |
| notes | Completed acquisition (Angelini Pharma closed its $4.1B acquisition of Catalyst Pharmaceuticals, funded partly by €1B of preferred equity... |
| source_urls | — |
| payload | {"signal_id"=>10360, "deal_status"=>"completed", "subject_role"=>"target", "counterparty_name"=>"Angelini Pharma"} |
| entered_by_person_id | — |
| entered_at | 2026-10-04T16:10:59.264195+00:00 |
| data_source | email_signal:19f78937b8d3426d |
| data_confidence | reported |